Related Experiment Video
Updated: Aug 19, 2025
09:03
Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
Published on: November 7, 2020
4.9K
Acute bronchiolitis during the COVID-19 pandemic
Patricia Flores-Pérez1, Nathalia Gerig2, Mª Isabel Cabrera-López1
1Pediatric Department, Hospital Universitario Niño Jesús, Madrid, Spain.
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)
|December 4, 2022
Summary
The COVID-19 pandemic significantly reduced bronchiolitis epidemics, with SARS-CoV-2 rarely causing severe cases. Rhinovirus was the primary cause of bronchiolitis during this period.
Area of Science:
- Pediatrics
- Infectious Diseases
- Epidemiology
Background:
- Bronchiolitis epidemics, typically occurring in autumn and winter, were notably absent during the initial year of the COVID-19 pandemic.
- The emergence of SARS-CoV-2 prompted an investigation into its role in respiratory infections among children.
Purpose of the Study:
- To characterize acute bronchiolitis cases during the fourth quarter of 2020.
- To determine the etiological role of SARS-CoV-2 in pediatric bronchiolitis during the COVID-19 pandemic.
Main Methods:
- A prospective, multi-center study was conducted in Madrid, Spain, from October to December 2020.
- Clinical data were collected from children admitted with acute bronchiolitis, and multiplex PCR was used for respiratory virus detection.
Main Results:
- Thirty-three children were hospitalized with bronchiolitis; 28 were caused by rhinovirus (RV), and 4 by SARS-CoV-2.
- SARS-CoV-2-associated bronchiolitis cases were similar to RV cases but had shorter hospital stays.
- A significant decrease in overall bronchiolitis admissions was observed, with no respiratory syncytial virus (RSV) detected.
Conclusions:
- SARS-CoV-2 is an infrequent cause of acute bronchiolitis and does not appear to be associated with severe clinical outcomes.
- The COVID-19 pandemic correlated with a substantial reduction in pediatric bronchiolitis hospitalizations.
Related Concept Videos
01:17Pulmonary Cycle: Exhalation
1.7K
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
1.7K
01:26COPD: Management Using Bronchodilators and Corticosteroids
275
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
275
01:21Acute Respiratory Failure-I
283
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
283
01:21Acute Respiratory Failure-II
314
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
314
01:30Acute Respiratory Failure-III
263
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
263
01:29Acute Respiratory Failure-V
182
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
182